Clinical Trial Update: LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes [Phase 3]

View source ↗

Summary

A Phase 3 study (LUNAR IIIb) comparing rosuvastatin and atorvastatin in subjects with acute coronary syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndromes | Phase 3 | Status: COMPLETED